Indian stocks: Visit www.stage2stocks.com →

China SXT Pharmaceuticals, Inc. Class A

Stage 4 · Declining · week 12

As of Oct 22, 2026, China SXT Pharmaceuticals is in Stage 4, the downtrend phase, now in week 12 (since Jul 30, 2026). It closed at $0.05, 100.0% below its 52-week high and below its 200-day average, which is falling.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. More about the company

$0.05
-34.25% today
$497,160 · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is SXTC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 49w
S4 27w
S3 19w
S4 22w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 49w → S1 3w → S4 27w → S1 1w → S2 11w → S3 19w → S4 2w → S1 1w → S4 12w → S1 1w → S4 22w → S1 6w → S4 12w current
Total tracked: 165 weeks across 13 stage runs.

SXTC among Drug Manufacturers - Specialty & Generic82nd of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…82SXTCStage 4 · wk 121−98.1%
vs 52W High
-100.0%
$0.05 lo$24,000.00 hi
100.0% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 12
1w13w26w
Week 12, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-100.0%
200 DMA: $379.73 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
2.21x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-98.1%
3M
-99.1%
6M
-100.0%
YTD
-100.0%
1Y
-100.0%
Scan Membership
Breakout Watch
Latest: 2025-03-03
2 appearances in last 60 days. First seen: 2021-01-26.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 12 · Vol 2.21x
2026-10-21S4
Wk 12 · Vol 11.14x
2026-10-20S4
Wk 12 · Vol 2.68x
2026-10-19S4
Wk 12 · Vol 4.92x
2026-10-16S4
Wk 12 · Vol 20.90x
2026-10-15S4
Wk 11 · Vol 5.47x
2026-10-14S4
Wk 11 · Vol 3.11x
2026-10-13S4
Wk 11 · Vol 6.14x
2026-10-12S4
Wk 11 · Vol 10.25x
2026-10-09S4
Wk 11 · Vol 19.78x
2026-10-08S4
Wk 10 · Vol 14.13x
2026-10-07S4
Wk 10 · Vol 87.31x
Moving averages & range
50 DMA
$2.25
200 DMA
$379.73
52W High
$24,000.00
52W Low
$0.05
5D Low
$0.05
Resistance levels (recent highs)
20d High
$3.01
60d High
$9.84
120d High
$214.40
250d High
$24,000.00
Next resistance
+6170.8%
to 20d High
ROE
-27.5%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 0.0

China SXT Pharmaceuticals: quick answers

What stage is China SXT Pharmaceuticals in?

As of Oct 22, 2026, China SXT Pharmaceuticals (SXTC) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 30, 2026 and is in week 12. What the four stages mean

Is China SXT Pharmaceuticals in an uptrend?

No. China SXT Pharmaceuticals is in a Stage 4 downtrend. It trades 100.0% below its 200-day average, which is falling.

How far is China SXT Pharmaceuticals from its 52-week high?

China SXT Pharmaceuticals closed at $0.05 on Oct 22, 2026, 100.0% below its 52-week high of $24,000.00. Its 52-week low is $0.05.

How has China SXT Pharmaceuticals performed over the past year?

As of Oct 22, 2026, China SXT Pharmaceuticals is down 100.0% over the past year and down 100.0% so far in 2026.

Which sector and industry is China SXT Pharmaceuticals in?

China SXT Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.